Related Experiment Videos
Cefotaxime is extensively used for surgical prophylaxis
1Department of Pathology, University of Iowa College of Medicine, Iowa City 52242.
American Journal of Surgery
|October 1, 1992
Summary
Cefotaxime, a third-generation cephalosporin, effectively prevents surgical site infections with single or short courses. This approach is cost-effective and reduces antibiotic resistance risks.
Area of Science:
- Infectious Diseases
- Surgical Prophylaxis
- Pharmacology
Background:
- Cefotaxime is a broad-spectrum, third-generation cephalosporin widely used for serious infections.
- Its favorable safety profile and antimicrobial spectrum support its use in surgical prophylaxis.
- Existing data support the efficacy of single-dose or short-course cefotaxime regimens.
Purpose of the Study:
- To review the efficacy and indications of cefotaxime prophylaxis in various surgical procedures.
- To evaluate the impact of cefotaxime on wound morbidity and antibiotic resistance.
- To assess the cost-effectiveness of limited-dose cefotaxime regimens.
Main Methods:
- Systematic review of over 11,500 published cefotaxime prophylaxis cases.
- Comparison with 10,500 control cases.
- Analysis of 98 cited references.
Main Results:
- Single-dose cefotaxime is indicated for hysterectomies, cesarean sections, GI, bone/joint, biliary, urologic, and some vascular surgeries.
- Short-course (3-4 doses) is recommended for colorectal, cardiac, head/neck, transplant, pediatric, and immunocompromised patients.
- Cefotaxime reduced wound morbidity in contaminated abdominal operations to <10%.
Conclusions:
- Single-dose or short-course cefotaxime regimens are effective, inexpensive, and reduce surgical wound morbidity.
- Transitioning to limited-dose cefotaxime minimizes risks of bacterial resistance and lowers hospital costs.
- Surgeons are encouraged to utilize cefotaxime for its patient and hospital benefits.